Masood Entezariasl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Masood Entezariasl has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Khatereh Isazadehfar
Department of Preventive and Community Medicine, Clinical Research Development Unit, Buali Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
6 shared publications Godrat Akhavanakbari
Ardabil University of Medical Sciences, Iran
3 shared publications- Ali Abitorabi
Department of Anesthesiology, School of Medicine, Fatemi Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
1 shared publication - AmirAhmad Arabzadeh
Department of Surgery, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
1 shared publication - Bita Shahbazzadegan
School of Medicine, Ardabil University of Medical Sciences, Ardabil, IR Iran
1 shared publication Fariba Kahnamoyiagdam
Ardabil University of Medical Sciences, Iran
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26
The effect of dexmedetomidine on emergence agitation and pain in post-anesthesia recovery of patients undergoing upper limb elective orthopedic surgery: a double-blind randomized clinical trial
Emergence agitation is a common complication following anesthesia, particularly impacting recovery in patients undergoing elective orthopedic surgeries. This study aimed to test the hypothesis that dexmedetomidine would reduce the incidence of emergence agitation and postoperative pain in patients undergoing upper limb orthopedic surgery under general anesthesia. This prospective, randomized, double-masked, placebo-controlled clinical trial was conducted at Fatemi Hospital in Ardabil, Iran. Patients scheduled for elective upper limb orthopedic surgeries were randomly assigned to receive either dexmedetomidine (0.4 µg/kg/hr) or a placebo during surgery. The primary outcome was the incidence of emergence agitation, assessed using the Riker Sedation-Agitation Scale. Secondary outcomes included: the severity of emergence agitation, postoperative pain intensity measured with the Visual Analog Scale, hemodynamic parameters, recovery time, and adverse events. A total of 150 patients were enrolled, with 75 in each group. Regarding the primary outcome, the dexmedetomidine group exhibited a significantly lower incidence of emergence agitation (14.7% vs. 48.0%, p = 0.001). Among secondary outcomes, the dexmedetomidine group reported lower pain scores (Visual Analog Scale: 2.32 ± 1.14 vs. 4.77 ± 0.79, p = 0.001) and showed significant differences in heart rate and systolic blood pressure, with lower values in the dexmedetomidine group (p = 0.022 and p = 0.008, respectively). The intraoperative infusion of dexmedetomidine significantly reduces the incidence of emergence agitation and is associated with improved postoperative pain management in adults undergoing elective upper limb orthopedic surgery. These findings support the use of dexmedetomidine as a beneficial adjunct in anesthetic practice to enhance recovery outcomes.
- 4 May 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26
Open AccessThe effect of dexmedetomidine on emergence agitation and pain in post-anesthesia recovery of patients undergoing upper limb elective orthopedic surgery: a double-blind randomized clinical trial
Emergence agitation is a common complication following anesthesia, particularly impacting recovery in patients undergoing elective orthopedic surgeries. This study aimed to test the hypothesis that dexmedetomidine would reduce the incidence of emergence agitation and postoperative pain in patients undergoing upper limb orthopedic surgery under general anesthesia. This prospective, randomized, double-masked, placebo-controlled clinical trial was conducted at Fatemi Hospital in Ardabil, Iran. Patients scheduled for elective upper limb orthopedic surgeries were randomly assigned to receive either dexmedetomidine (0.4 µg/kg/hr) or a placebo during surgery. The primary outcome was the incidence of emergence agitation, assessed using the Riker Sedation-Agitation Scale. Secondary outcomes included: the severity of emergence agitation, postoperative pain intensity measured with the Visual Analog Scale, hemodynamic parameters, recovery time, and adverse events. A total of 150 patients were enrolled, with 75 in each group. Regarding the primary outcome, the dexmedetomidine group exhibited a significantly lower incidence of emergence agitation (14.7% vs. 48.0%, p = 0.001). Among secondary outcomes, the dexmedetomidine group reported lower pain scores (Visual Analog Scale: 2.32 ± 1.14 vs. 4.77 ± 0.79, p = 0.001) and showed significant differences in heart rate and systolic blood pressure, with lower values in the dexmedetomidine group (p = 0.022 and p = 0.008, respectively). The intraoperative infusion of dexmedetomidine significantly reduces the incidence of emergence agitation and is associated with improved postoperative pain management in adults undergoing elective upper limb orthopedic surgery. These findings support the use of dexmedetomidine as a beneficial adjunct in anesthetic practice to enhance recovery outcomes.
- Open Access
- 16 December 2025
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 15 (6)
Prophylactic Role of Ketamine and Dexmedetomidine on the Prevention of Shivering in Patients Undergoing Inguinal Herniorrhaphy by Spinal Anesthesia: A Randomized Clinical Trial
Background: Numerous medical interventions have been utilized to prevent postoperative shivering. Due to the potential complications associated with the use of pethidine, such as respiratory failure, the exploration of alternative drugs for the prevention and treatment of postoperative shivering has been a key consideration. Objectives: The aim of this study was to assess the preventive effects of ketamine and dexmedetomidine on shivering in patients undergoing inguinal herniorrhaphy under spinal anesthesia. Methods: This triple-blind randomized clinical trial involved patients who were candidates for inguinal herniorrhaphy with spinal anesthesia. Patient, investigator/administering, and outcome assessor were blinded. The necessary sample size was 150, estimated based on statistical formula at a 95% confidence interval and 80% power. Patients were randomly assigned using a computer-generated random sequence allocation and a randomized block sampling design with block sizes of six to ensure balanced allocation across the three groups: Ketamine, dexmedetomidine, and control. Randomization was performed using random sequence allocation software and randomized block sampling with 6 blocks for all 3 treatment groups. The severity of shivering was assessed using the Bedside Shivering Assessment Scale (BSAS) at multiple time points: Immediately, 5, 15, and 30 minutes after spinal anesthesia, and upon entering the recovery room, 15 minutes later, and at discharge from recovery. Data were analyzed using IBM SPSS Statistics version 21 software. Quantitative data were expressed as mean ± standard deviation, while qualitative data were presented as percentages. The mean of the variables was compared using Student's t-test, and the chi-square test was employed to compare qualitative data. Results: The severity of shivering was notably lower in the dexmedetomidine group at 5, 15, and 30 minutes after spinal anesthesia induction, during recovery, and 15 minutes after recovery. The intensity of shivering upon exiting recovery was similar in the ketamine and dexmedetomidine groups and significantly lower than in the control group. Systolic blood pressure was significantly lower in the dexmedetomidine group upon entry into recovery and 15 minutes after recovery. Throughout all time periods, patients in the dexmedetomidine group exhibited significantly lower heart rates. Conclusions: Both ketamine and dexmedetomidine proved effective in reducing post-herniorrhaphy shivering compared to the control group, with the effect being notably greater in the dexmedetomidine group.
- 16 December 2025
- Published by Brieflands in Anesthesiology and Pain Medicine
- Vol. 15 (6)
Open AccessProphylactic Role of Ketamine and Dexmedetomidine on the Prevention of Shivering in Patients Undergoing Inguinal Herniorrhaphy by Spinal Anesthesia: A Randomized Clinical Trial
Background: Numerous medical interventions have been utilized to prevent postoperative shivering. Due to the potential complications associated with the use of pethidine, such as respiratory failure, the exploration of alternative drugs for the prevention and treatment of postoperative shivering has been a key consideration. Objectives: The aim of this study was to assess the preventive effects of ketamine and dexmedetomidine on shivering in patients undergoing inguinal herniorrhaphy under spinal anesthesia. Methods: This triple-blind randomized clinical trial involved patients who were candidates for inguinal herniorrhaphy with spinal anesthesia. Patient, investigator/administering, and outcome assessor were blinded. The necessary sample size was 150, estimated based on statistical formula at a 95% confidence interval and 80% power. Patients were randomly assigned using a computer-generated random sequence allocation and a randomized block sampling design with block sizes of six to ensure balanced allocation across the three groups: Ketamine, dexmedetomidine, and control. Randomization was performed using random sequence allocation software and randomized block sampling with 6 blocks for all 3 treatment groups. The severity of shivering was assessed using the Bedside Shivering Assessment Scale (BSAS) at multiple time points: Immediately, 5, 15, and 30 minutes after spinal anesthesia, and upon entering the recovery room, 15 minutes later, and at discharge from recovery. Data were analyzed using IBM SPSS Statistics version 21 software. Quantitative data were expressed as mean ± standard deviation, while qualitative data were presented as percentages. The mean of the variables was compared using Student's t-test, and the chi-square test was employed to compare qualitative data. Results: The severity of shivering was notably lower in the dexmedetomidine group at 5, 15, and 30 minutes after spinal anesthesia induction, during recovery, and 15 minutes after recovery. The intensity of shivering upon exiting recovery was similar in the ketamine and dexmedetomidine groups and significantly lower than in the control group. Systolic blood pressure was significantly lower in the dexmedetomidine group upon entry into recovery and 15 minutes after recovery. Throughout all time periods, patients in the dexmedetomidine group exhibited significantly lower heart rates. Conclusions: Both ketamine and dexmedetomidine proved effective in reducing post-herniorrhaphy shivering compared to the control group, with the effect being notably greater in the dexmedetomidine group.
- Open Access
- 29 January 2023
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 15 (1) , 39-44
The Effect of Nicotine Patch on Reducing Nausea, Vomiting, and Pain Following Laparoscopic Cholecystectomy: A Randomized Clinical Trial
Background: The effect of nicotine on nausea, vomiting, and postoperative pain has been investigated in studies on animals and humans. This study aimed to evaluate the effect of nicotine patch on decreasing nausea, vomiting, and pain in laparoscopic cholecystectomy. Methods: The study sample consisted of 100 non-smoking patients undergoing laparoscopic cholecystectomy under general anesthesia in a triple-blind clinical trial. One hour after the start of surgery, patients were randomly assigned to receive 17.5-mg nicotine or placebo patches. The patches located on the right arm were left for 24 hours. The visual analogue scale (VAS) for pain and N/V score for the severity of nausea and vomiting were measured at intervals of 0, 6, 12, and 24 hours. Findings: The results showed there was no statistically significant difference between the groups in terms of pain intensity as well as nausea and vomiting at different time periods after surgery (P>0.05). A total of 36 patients in the nicotine group and 24 patients in the placebo group received meperidine. There was also no statistically significant difference between the two groups in terms of analgesics (P=0.096) and antiemetics (P=0.1). Moreover, the frequency of severe nausea and vomiting during the study in the nicotine group was higher than in the placebo group (4 vs. 1) but this difference was not statistically significant (P>0.05). Conclusion: Receiving a 17.5-mg nicotine patch had a similar effect to receiving placebo in controlling postoperative pain, nausea, and vomiting in non-smokers. Nicotine use had no effect on reducing analgesia.
- 29 January 2023
- Published by Maad Rayan Publishing Company in Addiction & Health
- Vol. 15 (1) , 39-44
Open AccessThe Effect of Nicotine Patch on Reducing Nausea, Vomiting, and Pain Following Laparoscopic Cholecystectomy: A Randomized Clinical Trial
Background: The effect of nicotine on nausea, vomiting, and postoperative pain has been investigated in studies on animals and humans. This study aimed to evaluate the effect of nicotine patch on decreasing nausea, vomiting, and pain in laparoscopic cholecystectomy. Methods: The study sample consisted of 100 non-smoking patients undergoing laparoscopic cholecystectomy under general anesthesia in a triple-blind clinical trial. One hour after the start of surgery, patients were randomly assigned to receive 17.5-mg nicotine or placebo patches. The patches located on the right arm were left for 24 hours. The visual analogue scale (VAS) for pain and N/V score for the severity of nausea and vomiting were measured at intervals of 0, 6, 12, and 24 hours. Findings: The results showed there was no statistically significant difference between the groups in terms of pain intensity as well as nausea and vomiting at different time periods after surgery (P>0.05). A total of 36 patients in the nicotine group and 24 patients in the placebo group received meperidine. There was also no statistically significant difference between the two groups in terms of analgesics (P=0.096) and antiemetics (P=0.1). Moreover, the frequency of severe nausea and vomiting during the study in the nicotine group was higher than in the placebo group (4 vs. 1) but this difference was not statistically significant (P>0.05). Conclusion: Receiving a 17.5-mg nicotine patch had a similar effect to receiving placebo in controlling postoperative pain, nausea, and vomiting in non-smokers. Nicotine use had no effect on reducing analgesia.
- Open Access
- 1 January 2013
- Published by Medknow in Perspectives in Clinical Research
- Vol. 4 (3) , 165-8
The effects of oral pregabalin on post-operative pain of lower limb orthopedic surgery: A double-blind, placebo-controlled trial
Background: Post-operative pain is one of the problems, wherein lack of control on it has many side-effects such as tachycardia, hypertension, myocardial ischemia, decreased alveolar ventilation, and poor wound healing. Aims: In this study, we evaluated the pre-operative administration of pregabalin sufficiency and security in relieving post-operative pain after lower limb orthopedic surgery and reducing the need for opioids and their possible side-effects. Materials and Methods: This study is a randomized, double-blind clinical trial. It was performed on 60 patients under lower limb surgery by spinal anesthesia. Patients were randomly allocated to two groups, one group has received a 150 mg pregabalin capsule 2 h before surgery and the other group has received placebo as a control. In both groups at 2, 6, 12, and 24 h after surgery, the patients were evaluated and the pain score, the score of sedation, incidence of nausea and vomiting was recorded in the checklists. Then, the data were analyzed by SPSS v16. Results: Visual analog pain scores at all hours in pregabalin group significantly reduced compared to the placebo group ( P < 0.0001). Also, in the pregabalin group nausea and vomiting scores at all hours, sedation levels at 2 h and 6 h post-operatively, and pethidine consumption in all hours have significantly been reduced. Conclusion: A single pre-operative oral dose of pregabalin 150 mg is an effective method for reducing post-operative pain and pethidine consumption in patients undergoing orthopedic surgery.
- 1 January 2013
- Published by Medknow in Perspectives in Clinical Research
- Vol. 4 (3) , 165-8
Open AccessThe effects of oral pregabalin on post-operative pain of lower limb orthopedic surgery: A double-blind, placebo-controlled trial
Background: Post-operative pain is one of the problems, wherein lack of control on it has many side-effects such as tachycardia, hypertension, myocardial ischemia, decreased alveolar ventilation, and poor wound healing. Aims: In this study, we evaluated the pre-operative administration of pregabalin sufficiency and security in relieving post-operative pain after lower limb orthopedic surgery and reducing the need for opioids and their possible side-effects. Materials and Methods: This study is a randomized, double-blind clinical trial. It was performed on 60 patients under lower limb surgery by spinal anesthesia. Patients were randomly allocated to two groups, one group has received a 150 mg pregabalin capsule 2 h before surgery and the other group has received placebo as a control. In both groups at 2, 6, 12, and 24 h after surgery, the patients were evaluated and the pain score, the score of sedation, incidence of nausea and vomiting was recorded in the checklists. Then, the data were analyzed by SPSS v16. Results: Visual analog pain scores at all hours in pregabalin group significantly reduced compared to the placebo group ( P < 0.0001). Also, in the pregabalin group nausea and vomiting scores at all hours, sedation levels at 2 h and 6 h post-operatively, and pethidine consumption in all hours have significantly been reduced. Conclusion: A single pre-operative oral dose of pregabalin 150 mg is an effective method for reducing post-operative pain and pethidine consumption in patients undergoing orthopedic surgery.
- Open Access
- 1 January 2013
- Published by Medknow in Saudi Journal of Anaesthesia
- Vol. 7 (2) , 160-4
Comparison of the effects of remifentanil and alfentanil on intraocular pressure in cataract surgery
Background: Anesthesia for ophthalmic surgery requires management of intraocular pressure (IOP) during perioperative period. In an open eye, in conditions such as after traumatic injury or during cataract surgery, IOP increase can lead to permanent vision loss. Administration of narcotics concomitant with anesthetics has the ability to reduce this increase of IOP. This clinical trial aims to compare the efficacy of remifentanil and alfentanil in preventing an increase in IOP after administration of succinylcholine, intubation and during anesthesia. Methods: This double-blind clinical trial was conducted on 50 patients undergoing elective general surgery for cataracts. Patients were randomly divided into two groups. Alfentanil (20 μg/kg in 30 s) for group 1 and remifentanil (1 μg/kg in 30 s) for group 2 were injected before induction of anesthesia, and 0.5 μg/kg/min alfentanil for group 1 and 0.1 μg/kg/min remifentanil for group 2 were infused during the anesthesia. Systolic and diastolic blood pressure, heart rate, and IOP from normal eye were measured before the induction, after administration of thiopental and succinylcholine, after tracheal intubation, and 2 min later, and were repeated in 2-min intervals until the end of operation. Results: IOP decreased after injection of anesthetics and remained lower all through the operation in both groups, but IOP decreased after injection of succinylcholine in remifentanil group while it increased in alfentanil group (P<0.05). Conclusions: Results of this study indicate benefits of both remifentanil and alfentanil in managing IOP after induction and during anesthesia. It seems that remifentanil is better than alfentanil in controlling the IOP after injection of succinylcholine.
- 1 January 2013
- Published by Medknow in Saudi Journal of Anaesthesia
- Vol. 7 (2) , 160-4
Open AccessComparison of the effects of remifentanil and alfentanil on intraocular pressure in cataract surgery
Background: Anesthesia for ophthalmic surgery requires management of intraocular pressure (IOP) during perioperative period. In an open eye, in conditions such as after traumatic injury or during cataract surgery, IOP increase can lead to permanent vision loss. Administration of narcotics concomitant with anesthetics has the ability to reduce this increase of IOP. This clinical trial aims to compare the efficacy of remifentanil and alfentanil in preventing an increase in IOP after administration of succinylcholine, intubation and during anesthesia. Methods: This double-blind clinical trial was conducted on 50 patients undergoing elective general surgery for cataracts. Patients were randomly divided into two groups. Alfentanil (20 μg/kg in 30 s) for group 1 and remifentanil (1 μg/kg in 30 s) for group 2 were injected before induction of anesthesia, and 0.5 μg/kg/min alfentanil for group 1 and 0.1 μg/kg/min remifentanil for group 2 were infused during the anesthesia. Systolic and diastolic blood pressure, heart rate, and IOP from normal eye were measured before the induction, after administration of thiopental and succinylcholine, after tracheal intubation, and 2 min later, and were repeated in 2-min intervals until the end of operation. Results: IOP decreased after injection of anesthetics and remained lower all through the operation in both groups, but IOP decreased after injection of succinylcholine in remifentanil group while it increased in alfentanil group (P<0.05). Conclusions: Results of this study indicate benefits of both remifentanil and alfentanil in managing IOP after induction and during anesthesia. It seems that remifentanil is better than alfentanil in controlling the IOP after injection of succinylcholine.
- Open Access
- 1 January 2013
- Published by Medknow in Perspectives in Clinical Research
- Vol. 4 (2) , 136-41
The effects of indomethacin, diclofenac, and acetaminophen suppository on pain and opioids consumption after cesarean section
Background: Cesarean section is one of the common surgeries of women. Acute post-operative pain is one of the recognized post-operative complications. Aims: This study was planned to compare the effects of suppositories, indomethacin, diclofenac and acetaminophen, on post-operative pain and opioid usage after cesarean section. Materials and Methods: In this double-blind clinical trial study, 120 candidates of cesarean with spinal anesthesia and American Society of Anesthesiologists (ASA) I-II were randomly divided into four groups. Acetaminophen, indomethacin, diclofenac, and placebo suppositories were used in groups, respectively, after operation and the dosage was repeated every 6 h and pain score and opioid usage were compared 24 h after the surgery. The severity of pain was recorded on the basis of Visual Analog Scale (VAS) and if severe pain (VAS > 5) was observed, 0.5 mg/kg intramuscular pethidine had been used. Statistical Analysis Used: The data were analyzed in SPSS software version 15 and analytical statistics such as ANOVA, Chi-square, and Tukey's honestly significant difference (HSD) post-hoc. Results : Pain score was significantly higher in control group than other groups, and also pain score in acetaminophen group was higher than indomethacin and diclofenac. The three intervention groups received the first dose of pethidine far more than control group and the distance for diclofenac and indomethacin were significantly longer (P < 0.001). The use of indomethacin, diclofenac, and acetaminophen significantly reduces the amount of pethidine usage in 24 h after the surgery relation to control group. Conclusions : Considering the significant decreasing pain score and opioid usage especially in indomethacin and diclofenac groups rather than control group, it is suggested using of indomethacin and diclofenac suppositories for post-cesarean section analgesia.
- 1 January 2013
- Published by Medknow in Perspectives in Clinical Research
- Vol. 4 (2) , 136-41
Open AccessThe effects of indomethacin, diclofenac, and acetaminophen suppository on pain and opioids consumption after cesarean section
Background: Cesarean section is one of the common surgeries of women. Acute post-operative pain is one of the recognized post-operative complications. Aims: This study was planned to compare the effects of suppositories, indomethacin, diclofenac and acetaminophen, on post-operative pain and opioid usage after cesarean section. Materials and Methods: In this double-blind clinical trial study, 120 candidates of cesarean with spinal anesthesia and American Society of Anesthesiologists (ASA) I-II were randomly divided into four groups. Acetaminophen, indomethacin, diclofenac, and placebo suppositories were used in groups, respectively, after operation and the dosage was repeated every 6 h and pain score and opioid usage were compared 24 h after the surgery. The severity of pain was recorded on the basis of Visual Analog Scale (VAS) and if severe pain (VAS > 5) was observed, 0.5 mg/kg intramuscular pethidine had been used. Statistical Analysis Used: The data were analyzed in SPSS software version 15 and analytical statistics such as ANOVA, Chi-square, and Tukey's honestly significant difference (HSD) post-hoc. Results : Pain score was significantly higher in control group than other groups, and also pain score in acetaminophen group was higher than indomethacin and diclofenac. The three intervention groups received the first dose of pethidine far more than control group and the distance for diclofenac and indomethacin were significantly longer (P < 0.001). The use of indomethacin, diclofenac, and acetaminophen significantly reduces the amount of pethidine usage in 24 h after the surgery relation to control group. Conclusions : Considering the significant decreasing pain score and opioid usage especially in indomethacin and diclofenac groups rather than control group, it is suggested using of indomethacin and diclofenac suppositories for post-cesarean section analgesia.